{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:32:49Z","timestamp":1788492769904,"version":"build-2803163510"},"reference-count":8,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,12,7]],"date-time":"2005-12-07T00:00:00Z","timestamp":1133913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Dermatology"],"published-print":{"date-parts":[[2006,1]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> We have selectively targeted monocyte\/macrophages overexpressing an immunomodulatory molecule, latency\u2010associated peptide (LAP), a naturally occurring antagonist for transforming growth factor\u2010\u03b21, to murine skin utilizing UV light to produce a cutaneous influx of transduced monocyte\/macrophages. Bone marrow (BM) cells from BALB\/c mice were transduced <jats:italic>in vitro<\/jats:italic> with a retroviral construct containing green fluorescent protein (GFP) for detection and human LAP (hLAP) as a test molecule. The transduced BM cells were then cultured <jats:italic>in vitro<\/jats:italic> with granulocyte\u2010macrophage colony\u2010stimulating factor (GM\u2010CSF) to produce differentiation to monocyte\/macrophages. More than 80% of transduced BM cells were CD11b\u2010positive and MOMA\u2010positive by fluorescence\u2010activated cell\u2010sorter analysis and secreted LAP by ELISA after 10 days of culture in granulocyte\u2010macrophage colony\u2010stimulating factor (GM\u2010CSF). Transduced monocyte\/macrophages containing either GFP or hLAP\u2010GFP were then injected intravenously into BALB\/c mice. One\u2010half of recipients in each group were exposed to UVB (72\u2003mJ) to induce monocyte\/macrophage infiltration into skin. Recipients were sacrificed 60\u2003h after UV irradiation. We found transduced cutaneous macrophages expressing GFP by examining with fluorescence microscopy frozen skin sections of recipient mice immunostained with antibodies to GFP and to macrophage marker F4\/80. We identified hLAP sequences by polymerase chain reaction (PCR) of total DNA in recipient blood and UV\u2010irradiated skin but not in unirradiated skin. LAP sequences were also detected at much lower levels in other organs (lung, spleen, and liver) by PCR. Therefore, we have shown that genetically altered monocytic cells can be injected intravenously and targeted to mouse skin by UV exposure. This macrophage\u2010based gene\u2010transfer method may be a potentially useful immunotherapeutic approach for delivering monocyte\/macrophage\u2010derived products to skin.<\/jats:p>","DOI":"10.1111\/j.0906-6705.2005.00394.x","type":"journal-article","created":{"date-parts":[[2005,12,7]],"date-time":"2005-12-07T11:19:03Z","timestamp":1133954343000},"page":"51-57","source":"Crossref","is-referenced-by-count":6,"title":["Transduced monocyte\/macrophages targeted to murine skin by UV light"],"prefix":"10.1111","volume":"15","author":[{"given":"Alexandra Y.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar A.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita C.","family":"Gilliam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,12,7]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.9.9.2069"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12365802"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1042\/0264-6021:3520601"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00481a014"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/me.6.5.694"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.12.5877"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008909908180"},{"key":"e_1_2_7_9_2","unstructured":"FDA places temporary halt on gene therapy trails using retroviral vectors in blood stem cells. FDA Talk Paper vol 2003. Available athttp:\/\/www.fda.org 2003"}],"container-title":["Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0906-6705.2005.00394.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T23:47:49Z","timestamp":1697068069000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0906-6705.2005.00394.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,7]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["10.1111\/j.0906-6705.2005.00394.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0906-6705.2005.00394.x","archive":["Portico"],"relation":{},"ISSN":["0906-6705","1600-0625"],"issn-type":[{"value":"0906-6705","type":"print"},{"value":"1600-0625","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,7]]}}}